Description
Strofantin-Darnitsa (g-strophanthin) Solution for Injection 0.025% – 1ml Ampoules #10
Strofantin-Darnitsa, also known as g-strophanthin, is a potent cardiac glycoside medication used for the treatment of various heart conditions. This solution for injection is formulated at a concentration of 0.025% in 1ml ampoules, with each package containing 10 ampoules.
Overview
Strofantin-Darnitsa is derived from the seeds of the plant Strophanthus gratus and is known for its positive inotropic effects on the heart. It works by increasing the force of contraction of the heart muscle, thereby improving cardiac output and circulation. This medication is commonly used in the management of conditions such as heart failure, atrial fibrillation, and other cardiac arrhythmias.
Indications
Strofantin-Darnitsa is indicated for the following conditions:
- Heart failure
- Atrial fibrillation
- Cardiac arrhythmias
Mechanism of Action
Strofantin-Darnitsa exerts its pharmacological effects by inhibiting the sodium-potassium ATPase pump in cardiac myocytes. This leads to an increase in intracellular calcium levels, which in turn enhances cardiac muscle contraction. The improved contractility of the heart helps to increase cardiac output and improve circulation in patients with heart conditions.
Dosage and Administration
The dosage of Strofantin-Darnitsa solution for injection should be determined by a healthcare professional based on the patient’s individual condition and response to treatment. It is usually administered intravenously, and the injection should be given slowly to avoid adverse reactions.
Contraindications
Strofantin-Darnitsa is contraindicated in patients with the following conditions:
- Hypersensitivity to cardiac glycosides
- Ventricular tachycardia
- Heart block
- Severe renal impairment
Adverse Reactions
Common adverse reactions associated with Strofantin-Darnitsa may include:
- Nausea
- Vomiting
- Cardiac arrhythmias
- Visual disturbances
- Headache
Precautions
Patients receiving Strofantin-Darnitsa should be closely monitored for signs of toxicity, including changes in heart rate and rhythm. It is important to maintain adequate potassium levels in patients taking this medication, as hypokalemia can increase the risk of cardiac side effects.
Storage
Strofantin-Darnitsa solution for injection should be stored at room temperature away from light and moisture. It should be kept out of reach of children and disposed of properly after use.
Conclusion
Strofantin-Darnitsa is a valuable medication for the treatment of various heart conditions, providing positive inotropic effects and improving cardiac function. When used appropriately and under the supervision of a healthcare professional, this medication can help manage symptoms and improve outcomes in patients with heart failure and other cardiac disorders.
